EdwinNNeumann Profile Banner
Edwin Neumann Profile
Edwin Neumann

@EdwinNNeumann

Followers
309
Following
476
Media
2
Statuses
27

PhD student @MITdeptofBE in the lab of Jonathan Weissman @Jswlab @WhiteheadInst || BS '19 @UWMadison || he/him || Epigenome editing enthusiast

Cambridge, MA
Joined July 2020
Don't wanna be here? Send us removal request.
@EdwinNNeumann
Edwin Neumann
1 year
Sharing my first 1st author paper, now published in Science! For my PhD I engineered CHARM, a compact, enzyme-free epigenetic editor which can be delivered via AAV vector to reach the brain. This work was done in @JswLab with @TessaBertozzi and @ElaineWu0 https://t.co/DrV4EGe92z
16
75
501
@dougblandry
Doug Landry
6 months
But how is anyone supposed to know where to go? These maps are the sum total of what they put out and they’re total garbage How is a regular person supposed to figure this out?
52
282
4K
@baym
Michael Baym
10 months
We live in an age of (NIH-funded) biomedical miracles Within your lifetime, prion disease was considered potentially impossible to cure. Now there's a promising path towards one https://t.co/HdW6nPrTVS
Tweet card summary image
science.org
Prion disease is caused by misfolding of the prion protein (PrP) into pathogenic self-propagating conformations, leading to rapid-onset dementia and death. However, elimination of endogenous PrP...
5
94
489
@EdwinNNeumann
Edwin Neumann
1 year
Sharing my first 1st author paper, now published in Science! For my PhD I engineered CHARM, a compact, enzyme-free epigenetic editor which can be delivered via AAV vector to reach the brain. This work was done in @JswLab with @TessaBertozzi and @ElaineWu0 https://t.co/DrV4EGe92z
16
75
501
@EdwinNNeumann
Edwin Neumann
1 year
We believe this will forge a path to a much-needed prion disease treatment, and we think CHARM could potentially be applied to other neurodegenerative diseases. Please also check out this excellent perspective piece by @mn_whittaker and @kiranmusunuru! https://t.co/SpzJ8PdWQf
Tweet card summary image
science.org
A new class of editor has improved delivery, durability, tunability, and safety
1
7
37
@EdwinNNeumann
Edwin Neumann
1 year
Working with @FionaSerack & co. in the lab of prion experts Sonia Vallabh and Eric Minikel @cureffi, along with AAV expert Ben Deverman @DevermanLab & co., we demonstrate that CHARM can potently repress the prion protein throughout the mouse brain.
1
2
10
@WhiteheadInst
Whitehead Institute
1 year
.@JswLab and @broadinstitute collaborators have developed a gene-silencing tool that shows promise as a therapy against fatal prion diseases. The tool, called CHARM, paves the way for a new class of genetic approaches to treat certain diseases: https://t.co/5RjeUkx3J1
0
8
43
@cureffi
Eric Vallabh Minikel
1 year
Introducing CHARM: a new epigenome editor to methylate DNA at the promoter of a targeted gene. Our lab's collaboration with @JswLab's @EdwinNNeumann & @TessaBertozzi shows deep silencing of brain PrP Paper: https://t.co/HZRKk2m1b2 Blog: https://t.co/crVVYpyI6w
5
150
543
@GayathriArunaM
Gayathri Muthukumar
2 years
Excited to share my first paper from grad school out today in @MolecularCell! We systematically define biogenesis pathways for alpha-helical OMM proteins triaged by the NAC and TTC1 chaperone complexes for polytopic and signal-anchored proteins (1/2). https://t.co/UGB8yhKnBW
Tweet card summary image
cell.com
Muthukumar et al. use genome-wide and systematic arrayed CRISPRi screens to identify ⍺-helical OMM protein biogenesis and quality control factors that triage substrates by topology. They establish...
4
21
39
@cureffi
Eric Vallabh Minikel
2 years
On @medrxivpreprint today, we describe the plasma & CSF biomarker changes leading up to symptom onset in 4 cohort study participants who went on to develop active prion disease https://t.co/behU25E1IN
1
16
55
@davidrliu
David R. Liu
2 years
Three of the more costly and frequently used reagents in molecular biology are rolling circle amplification (RCA) mix, chemically competent MachOne (or other E. coli) cells, and Gibson assembly mix. Postdoc Julian Willis—who is starting his own lab in the UK soon—developed
32
464
2K
@JswLab
Jonathan Weissman's Lab
3 years
We are looking for a motivated recent grad (or soon-to-be grad) to join us as a lab technician! A great opportunity to gain research experience for 2-3 years before applying to MD and/or PhD programs. Apply here:
0
11
23
@JuliaJoung
Julia Joung
3 years
Thrilled to share my primary PhD work: a Transcription Factor Atlas for understanding gene regulation and cell engineering @CellCellPress. We created a comprehensive TF ORF library and applied it to profile resulting expression changes. A thread 1/X
28
294
1K
@EdwinNNeumann
Edwin Neumann
3 years
Exciting work from my undergrad lab. Coral was an amazing mentor!
@SridharanLab
SridharanLab
3 years
Our discovery of changing cell identity by controlling histone modifications in the gene body (not enhancers) at essential housekeeping genes (not lineage specifying factors) is at https://t.co/DwcbJYWlDK 🧵
0
0
10
@josephmreplogle
Joseph Replogle
3 years
Our genome-scale Perturb-seq paper is out today in Cell! https://t.co/ErZZWSJ3VB @CellCellPress @JswLab Thanks to all the authors and reviewers for their contributions. See the thread below for key findings.
18
221
866
@dianyang1117
Dian Yang
4 years
Excited to share our work using a CRISPR-based lineage tracer to track tumor evolution from a single transformed cell to an aggressive tumor in a genetically engineered KP-Tracer model. It is a great collaboration of the @JswLab, @LabJacks and @YosefLab. https://t.co/at5yMZmtlF
Tweet card summary image
cell.com
Yang et al. developed a genetically engineered mouse model of lung cancer capable of continuous lineage tracing with single-cell RNA-seq readout. They identified the subclonal dynamics of tumors,...
14
58
270
@JswLab
Jonathan Weissman's Lab
4 years
We are looking for a motivated recent grad to join us as a lab technician! Perfect opportunity to gain more research experience for 2-3 years before applying to MD and/or PhD programs. Follow the link below to apply: 👉
2
35
63
@JuliaJoung
Julia Joung
4 years
Excited to share the latest work from my PhD! We performed the first CRISPR activation screen to identify genes that drive solid tumor resistance to T cell-mediated cytotoxicity. A thread 1/X https://t.co/GFZfSw0KnS
7
117
606
@CellCellPress
Cell
5 years
Dual modes of #CRISPR-associated #transposon homing. Now online! https://t.co/WT8VL9uM2l
0
13
46